Market Overview
According to fortune business insights, the global exosome research market size was valued at USD 159.1 million in 2025. The market is projected to grow from USD 177.5 million in 2026 to USD 458.8 million by 2034, exhibiting a CAGR of 12.61% during the forecast period. North America dominated the global exosome research market with a market share of 43.37% in 2025.
The analysis shows that the market is witnessing strong growth driven by the rising global cancer burden, a strong emphasis on biomarker discovery, and a shift toward personalized medicine. Key industry players such as Thermo Fisher Scientific Inc. and QIAGEN are shaping the market through innovative product offerings and strategic initiatives.
Major Players Profiled in the Market Report:
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- Lonza (Switzerland)
- System Biosciences, LLC. (U.S.)
- Danaher (U.S.)
- FUJIFILM Corporation (Japan)
- IZON Science LTD (New Zealand)
- STEMCELL Technologies (Canada)
- RoosterBio, Inc. (U.S.)
- Spectris (U.S.)
Segments
Rising Demand for Reagents and Kits to Propel Products Segment Growth
Based on offering, the market is divided into products and services. The product segment is expected to capture the largest market share due to the high usage of reagents and kits in research applications.
Importance of Isolation in All Applications to Drive Segment Growth
By workflow, the market is segmented into isolation & purification, characterization, profiling, and others. The isolation & purification segment holds the largest market share, projected at 36.0% in 2026, as it is the essential first step for all downstream exosome research activities.
High Focus on Biomarker Discovery to Propel Segment Expansion
Based on application, the market is divided into biomarker discovery & liquid biopsy research, exosome therapeutics research, and others. The biomarker discovery & liquid biopsy research segment is leading the market, projected to account for a 53.1% share in 2026, as exosomes are ideal carriers for disease detection and monitoring.
Academic & Research Institutes to Dominate the Market Due to High Research Volume
By end-user, the market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, and others. The academic & research institutes segment holds the largest market share (projected 49.3% in 2026) as the majority of exosome studies are discovery-driven and concentrated in these institutions.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
For detailed market insights: https://www.fortunebusinessinsights.com/exosome-research-market-115249
Report Coverage
The report offers:
- Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
- Comprehensive insights into regional developments.
- A list of major industry players and their profiles.
- Key strategies adopted by the market players, such as collaborations and partnerships.
- The latest industry developments, including new product launches and strategic initiatives.
Drivers & Restraints
Rising Global Cancer Burden to Propel Market Growth
The increasing global incidence of cancer is a major market driver, expanding the need for early detection and monitoring where exosome-based liquid biopsies are a preferred option. This boosts the demand for exosome isolation kits, characterization, and profiling services for high-throughput biomarker discovery. The WHO predicts new cancer cases will exceed 35 million by 2050.
However, the high cost of advanced analytical instruments, such as nanoparticle tracking analysis (NTA) systems which can cost over USD 94,000, may restrain market growth by limiting access for smaller labs.
Regional Insights
Strong Life Science Funding Propels Market Growth in North America
North America holds the dominant market share, valued at USD 69.0 million in 2025. The region’s leadership is attributed to strong life science funding, advanced research infrastructure, and early adoption of novel molecular analysis technologies. The U.S. market alone is projected to reach USD 73.2 million in 2026.
Europe is the second-largest market, projected to reach USD 46.0 million by 2026. Its growth is supported by collaborative academic networks and strong cancer and biomarker research programs.
Asia Pacific is the third-largest region, projected to be valued at USD 35.0 million in 2026, with growth driven by expanding biomedical research investment and infrastructure development.
Exosome Research Market Trends
A significant trend is the integration of exosome analysis with multi-omics platforms (proteomics, transcriptomics, metabolomics) for deeper biological insights. This approach improves biomarker robustness and helps link exosome subtypes to biological function and disease states, driving investment in advanced bioinformatics and AI pipelines. For instance, in June 2025, Mursla Bio launched its AI Precision Medicine Platform built on multi-omics profiling of organ-specific exosomes.
Competitive Landscape
Emphasis on Strategic Initiatives and New Product Launches to Strengthen Market Share
The market is semi-fragmented, with prominent players like Thermo Fisher Scientific Inc., QIAGEN, and Lonza holding a major share due to their strong global presence, wide distribution networks, and broad product portfolios. Key strategies include new product development, collaborations, and partnerships to gain market share.
Key Industry Developments
- July 2025: CD Bioparticles introduced Purified Exosomes to support drug delivery and therapeutic research applications.
- April 2025: Thermo Fisher Scientific Inc. and RoosterBio Inc. announced a collaboration to advance cell & exosome therapy manufacturing.
- April 2025: Particle Metrix launched ZetaView Evolution, a next-generation nanoparticle tracking analysis system for exosome characterization.
- January 2024: EXO Biologics launched ExoXpert, an exosome-focused CDMO offering a manufacturing platform for clinical trials.
Uncover Japan’s Market Trends - Explore the Latest Exosome Research Market Insights
Comments